Detalhe da pesquisa
1.
Exosomes in multiple myeloma: from bench to bedside.
Blood
; 140(23): 2429-2442, 2022 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271699
2.
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma.
Haematologica
; 109(1): 256-271, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37470139
3.
Targeting mTOR signaling pathways in multiple myeloma: biology and implication for therapy.
Cell Commun Signal
; 22(1): 320, 2024 Jun 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38862983
4.
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
J Pathol
; 260(2): 112-123, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807305
5.
Targeting the ß2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
J Pathol
; 259(1): 69-80, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245401
6.
Single-cell analysis at the protein level delineates intracellular signaling dynamic during hematopoiesis.
BMC Biol
; 19(1): 201, 2021 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503511
7.
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.
Int J Mol Sci
; 23(2)2022 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35055096
8.
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
Br J Cancer
; 120(12): 1137-1146, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31089208
9.
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
J Pathol
; 241(4): 534-546, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27976373
10.
Metabolic Features of Multiple Myeloma.
Int J Mol Sci
; 19(4)2018 Apr 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29662010
11.
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
J Pathol
; 239(2): 162-73, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26956697
12.
Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.
Blood
; 124(4): 555-66, 2014 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-24928860
13.
Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.
Br J Haematol
; 167(5): 651-63, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25142285
14.
Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition.
Blood
; 119(3): 826-37, 2012 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-22128141
15.
Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.
Cancer Res
; 84(1): 39-55, 2024 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37756570
16.
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia.
Theranostics
; 14(7): 2656-2674, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38773967
17.
Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
Stem Cells
; 30(2): 266-79, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22102554
18.
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.
J Immunother Cancer
; 11(1)2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36650020
19.
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
Front Immunol
; 14: 1286700, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38035078
20.
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
Blood Cancer J
; 13(1): 188, 2023 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38110349